Literature DB >> 28600172

Conditional knockout of microRNA-31 promotes the development of colitis associated cancer.

Zhaoyuan Liu1, Jing Bai1, Lingyun Zhang1, Fangzhou Lou1, Fang Ke1, Wei Cai1, Honglin Wang2.   

Abstract

MicroRNA-31 (miR-31) is an evolutionarily conserved microRNA, and its biological function in colorectal cancer and other cancers is controversial. In this study, we identified the host gene of mouse miR-31 and found that miR-31 was over-expressed in both human colorectal cancer and mouse colon cancer models. We here developed a miR-31 conditional knockout mouse model that allows for colon epithelium specific deletion of miR-31 to investigate its functionality in colon cancer development. We demonstrated that mice with miR-31 conditional deletion resulted in more severe colitis-associated cancer than wild-type, and we further identified Wdr5 as an important target of miR-31.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Mir31hg; Wdr5; miR-31; miR-31 knockout

Mesh:

Substances:

Year:  2017        PMID: 28600172     DOI: 10.1016/j.bbrc.2017.06.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2019-12-11       Impact factor: 5.914

Review 2.  Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review.

Authors:  Rita Modesto; João Estarreja; Inês Silva; João Rocha; Rui Pinto; Vanessa Mateus
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

Review 3.  MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Victoria Piurowski; Brooke Rigot; Carlo M Croce
Journal:  Curr Opin Pharmacol       Date:  2017-11-15       Impact factor: 5.547

Review 4.  microRNA-based diagnostic and therapeutic applications in cancer medicine.

Authors:  Lorenzo F Sempere; Asfar S Azmi; Anna Moore
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-17       Impact factor: 9.957

Review 5.  The Emerging Role of Major Regulatory RNAs in Cancer Control.

Authors:  Xiaofeng Dai; Aman Chandra Kaushik; Jianying Zhang
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

6.  Histone Deacetylase-3 Modification of MicroRNA-31 Promotes Cell Proliferation and Aerobic Glycolysis in Breast Cancer and Is Predictive of Poor Prognosis.

Authors:  Yunfei Zhao; Jiao He; Ling Yang; Qichi Luo; Zhi Liu
Journal:  J Breast Cancer       Date:  2018-06-20       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.